Wednesday, April 24, 2024
Home Awards Press Release: National Cancer Institute awards ICF New $161 Million Digital Modernization task order

Press Release: National Cancer Institute awards ICF New $161 Million Digital Modernization task order

0
Press Release: National Cancer Institute awards ICF New $161 Million Digital Modernization task order
jquery-3.2.1.min.js

The National Institutes of Health (NIH) National Cancer Institute (NCI) recently awarded global consulting and technology services provider ICF (NASDAQ:ICFI) a new $161 million task order to provide digital modernization services. The task order, which was the first awarded to the company under the Center for Biomedical Informatics and Information Technology (CBIIT) IT blanket purchase agreement, has a term of five years, including a six-month base and nine six-month options.

ICF will partner with CBIIT to deliver mission-focused technology solutions and software-enabled services through its Digital Services Center (DSC) to support the research, grants and administrative needs of NCI divisions.

“The DSC will serve as a strategic hub, bringing together numerous disparate systems to provide centralized access to the data science, IT and data sharing tools needed by NCI staff and the cancer research community to advance our knowledge of cancer to improve health outcomes,” said Mark Lee, ICF executive vice president and chief technology executive. “We are excited to partner with NCI to provide strategic, pragmatic solutions to improve collaboration across these organizations which will ultimately help CBIIT better achieve its critical research mission.”

In performing this work, the company will bring its unique combination of deep health domain expertise and leading-edge technology solutions plus extensive experience supporting NCI programs to establish a strategy, roadmap and architecture to drive innovation and optimization and accelerate the pace of NCI’s enterprise modernization efforts… Read the full press release here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here